(Mary Ann Liebert, Inc./Genetic Engineering News) Using RNA interference (RNAi) technology to silence an immune-stimulating complex in endothelial cells (EC), the main cellular component of blood vessels, researchers have made it possible to use the plentiful supply of donor ECs instead of a patient’s own cells to generate tissue engineered vascular grafts for transplantation.